InVivo Therapeutics Holdings Corp. Message Board
-
if i was smart, i'd move everything over to here at least till we hit $2.50, because it has shown over and over it is fully cable of moving to that point
Sentiment: Strong Buy
-
those SA bash articles really do work. AMRN has now got to be the absolute best biotech buy available here at $7.50's. unbelivable
Sentiment: Strong Buy
-
this will make two days in a row it has moved up and looks like no one wants to sell at this point which makes sense. Huge catalyst are very close and it's still got a very low market cap. At the point they show early success in one of the trials, I would expect the stock to be about triple what it is now. Since it's open label, that may not be far off, maybe as soon #$%$ months.
glta longs, all imoSentiment: Strong Buy
-
if it hits 2.50 i will be adding for a4th time, but i'd be pretty surprised to see it go that low. But the longer the wait for human trials goes, outta sight, outta mind with alot of investors.
- Reply to
I believe I would get a chance to load after tomorrow's ER
by galoishe •Feb 27, 2013 5:41 PMlol, it will be ER in Sep before any attention is paid to sales. That will be the first qtrly report to have sales for an entire qtr. And it will be a year and a half before the sales numbers are true, after all the freebies expire. Script numbers and Anchor will move this until then. i don't expect any drop.
Sentiment: Strong Buy
- Reply to
looks like NVIV is in the midst of that run to $2.50 again
by alabamatigers11u •Feb 26, 2013 11:55 AMIf the market believes that indeed HUD and IDE could get approvals by end of March, then i would not be surprised to see NVIV go well past $2.50 and at least to around $3. Because once they start human trials, we are looking at around $5, and when they announce positive results on humans, we will be looking at around $10. Plus these trials don't take as long as typical drug trials, plus NVIV has so much more coming down the road. Buying at this level could be an amazing opportunity if the company is successful. Anywhere under $2.50 imo is a steal if you truly believe in the companys goals and ability to achieve them.
Sentiment: Strong Buy
-
in any case, very exciting times ahead this month
Sentiment: Strong Buy
- Reply to
Unmistakeable stair step pattern as we approach end of month
by cynicoptimist •Mar 16, 2013 11:01 AMalso you'll notice our bd slowly turn to garbage as bashers start showing up. It's just the way it is when a bio has a major catalyst coming. if there was ever a time to be buying NVIV, I would think it is right now. This could really surge as we get closer to the end of the month.
Sentiment: Strong Buy
-
those bashing SA bozo's are buying out the other side of their mouth. When a partner gets announced for anchor indication, watch out!!!
-
shorts switching to long positions here now, The bottom was 7.50, nothing but positive growth ahead now. glta longs
Sentiment: Strong Buy
-
glta longs
Sentiment: Strong Buy
-
Will take some time for Vascepa to gain traction, but it will. Just have to be patient. Also Vascepa market increases 10 fold by Dec 2013 after Anchor trial approval. GLTA and do your own dd, all imo
Sentiment: Strong Buy
- Reply to
I Am In // Did DD & This Is One Of The Most Undervalued Biotechs On The Market.
by tradinghulkman •Mar 28, 2013 11:27 AMyep, wish i was buying more here, but fully loaded already, gltu
-
may see a string of settlements soon, VRNG says we ain't playin' games
Sentiment: Strong Buy
-
thanks, that should provide a catalyst for some upward movement
-
This is a unique field / solution and i expect additional grant money to come their way to help with the trial cost. They have been good at securing grants in the past, all imo, glta longs and NVIV. Next catalyst probably warrant conversion finalization in about 3 weeks, then a possible move to the nasdaq 3 wekks or so after that, then official trial start a few weeks later after that, hmm, getting exciting here. Plus should probably hear about a hydrogel partner soon, i think they had hoped to announce that by years end 2012, so maybe we hear something on that soon too?? all imo, do your own dd.
Sentiment: Strong Buy
-
should hear some news about uplisting soon. They may combine it with news of first patient starting trial. Two big pieces of news to hit between now and about 6 weeks from now. should be interesting trading. I expect some big boys to start taking positions soon and drive this to around 3.50 before we hear about the trial starting. right now is a great time to buy in imo, do your own dd and glta longs and NVIV
Sentiment: Strong Buy
-
AMRN has 1bil potential FDA approved drug now, and thuis week sNDA will be submitted that makes it a 10bil potential drug. Don't listen to AL H, just look at the poor AFFY people, sad, sad
Sentiment: Strong Buy
- Reply to
looks like NVIV is in the midst of that run to $2.50 again
by alabamatigers11u •Feb 26, 2013 11:55 AMsame here, i want to stay somewhat diversified. I like the long term potential of the other stuff I'm in.
Sentiment: Strong Buy